Filter
14
Filtered Results: 14
Text search:
The
Pediatric
Praziquantel
Consortium
Featured
Recommendations
1
Language
Document type
Studies & Reports
5
Strategic & Response Plan
2
No document type
2
Manuals
1
Brochures
1
Resource Platforms
1
Guidelines
1
Infographics
1
Countries / Regions
Kenya
1
Global
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Schistosomiasis
1
Pediatrics
1
Guidelines
1
Studies & Reports
1
NTDs & Others
1
Toolboxes
Capacity Building & Resources
3
Studies & Reports
3
Local Action
1
Health Equity & Equality
1
Essential Medicines
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Studies & Reports
1
NTDs General
1
Overview, Studies & Reports
1
Prevention & Control
1
The consortium is an international public-private partnership that aims to reduce the global disease burden of schistosomiasis by addressing the medical needs of infected children between the ages of 3 months and 6 years. By doing so, we hope to contribute to the ongoing efforts to eliminate schisto...
The Pediatric Praziquantel Consortium was founded in July 2012 as the first international, non-profit, public-private partnership in schistosomiasis, supported by world leading experts in tropical parasitic infectious diseases.
PLOS Glob Public Health 4(12): e0004035. https://doi. org/10.1371/journal.pgph.0004035.
A new formulation of praziquantel, arpraziquantel (arPZQ), has been developed for preschool-
aged children (PSAC) to fill the treatment gap for this age group in schistosomiasis control and
elimination program...
Technology landscape
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Lancet Infectious Diseases Volume 22, Issue 11e327-e335.
In February, 2022, WHO published new guidelines with six recommendations to update the global public health strategy against schistosomiasis, including expansion of preventive chemotherapy eligibility from the predominant group of school-age...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
Schistosomiasis is a public health problem in tropical and subtropical regions of Africa, Asia, the Caribbean and South America. It is one of the neglected tropical diseases (NTDs) - a group of diseases and conditions that affect particularly low-income populations, worldwide.
Last year, WHO laun...
Lancet. 2014 June 28; 383(9936): 2253–2264. doi:10.1016/S0140-6736(13)61949-2. Review Article
Lancet Infect Dis 2020 Published Online May 5, 2020 https://doi.org/10.1016/ S1473-3099(20)30254-1
Diese Broschüre möchte dazu beitragen, dass möglichst viele Menschen die Ergebnisse öffentlich finanzierter Forschung nutzen können.
